Prostate cancer book includes discussion on PSA, DRE, active surveillance

In this video, Andrew L. Siegel, MD, outlines the contents of his book “Prostate Cancer 20/20: A Practical Guide to Understanding Management Options for Patients and Their Families.” Siegel is a urologist in Maywood, New Jersey.

Transcription:

Is there anything you would like to add?

Additionally, I have it illustrated as well. I added about a dozen new illustrations, because a picture is worth 1000 words; it's very helpful instead of narrative concepts, so I thought that was helpful. I did a bunch on screening guidelines, because that's always been a huge controversy. When do you start doing PSAs? How often do you start doing PSAs? When do you stop doing PSAs? Digital rectal examination [is] another huge controversy. The vast majority of primary medical doctors don't even do digital rectal examinations anymore. I had written a little article up for Doximity entitled "A Plea to PCPs: Please Do a Digital Rectal Exam on Male Patients (or Refer to Urology)." It set up this heated discussion with 500 different replies from people denouncing DREs to others saying how fundamentally important they are. I tried to cover that as well as I could. [I also covered] active surveillance. 31% of men now are diagnosed with grade group 1 Gleason 6, so we're doing a whole lot of active surveillance. I expanded that chapter quite a bit. I tried to cover the focal therapies, at least just review some of the new ones that are coming in, even though they're still not necessarily 100% mainstream. I mentioned some ongoing clinical trials and a plea of patients to try to enlist in clinical trials for future men with prostate cancer. I think that about covers it.

This transcription was edited for clarity.